Joseph Beechem has left his position as head of advanced sequencing and global sequencing chemistry, biochemistry, and biophysics at Life Technologies to join NanoString as senior vice president of research and development.
While at Life Tech, he led the design and development of multiple sequencing technologies for the SOLiD platform, including an emulsion PCR-free sample-prep technology called WildFire that Life Tech plans to launch this year. He holds a BS in chemistry and biology from Northern Kentucky University and a PhD in biophysics from Johns Hopkins University.
Beechem has also served as chief technology officer at Life Tech, chief scientific officer of Invitrogen, and director of biosciences at Molecular Probes.
Hugh Martin has resigned from Pacific Biosciences' board of directors for personal reasons, effective immediately. Martin was previously the firm's president and CEO but resigned at the beginning of the year and was replaced by Michael Hunkapiller (IS 1/10/2012). He had led the company since 2004 and has been battling multiple myeloma, with which he was diagnosed in 2009.